Why the study?
Is Left Cardiac Sympathetic Denervation feasible and safe in patients with symptomatic systolic heart failure?
Is Left Cardiac Sympathetic Denervation feasible and safe in patients with symptomatic systolic heart failure?
Answers are grounded in this paper and cite their sources.
Left Cardiac Sympathetic Denervation appears feasible and safe in patients with systolic heart failure, warranting larger randomized trials.
LCSD was feasible and seemed to be safe in systolic HF patients. Its beneficial effects warrant the development of a larger randomized trial. Trail registration: NCT01224899.
No takes yet. Share an insight, caveat, or question.
Conceição‐Souza et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: